Timothy S. Naimi, MD, MPH

Adjunct Professor, Medicine

Timothy Naimi
801 Massachusetts Ave Crosstown Center


Timothy Naimi M.D., M.P.H is a physician and alcohol epidemiologist at Boston Medical Center (BMC), and a Professor with the Boston University Schools of Medicine and Public Health. Dr. Naimi received his bachelor’s degree from Harvard College, his M.D. degree from the University of Massachusetts, and his M.P.H degree from the Harvard School of Public Health. He completed a combined internal medicine-pediatrics residency program at the Massachusetts General Hospital, the Epidemiologic Intelligence Officer program with the Centers for Disease Control and Prevention (CDC), and a preventive medicine residency with the CDC. Prior to coming to BMC, Dr. Naimi worked as a clinician for the U.S. Indian Health Service, and as a senior epidemiologist with the Alcohol Team at CDC. His current research interests, for which he receives grant support from the National Institutes of Health and CDC, include binge drinking, youth drinking, health effects of low-dose ethanol, and substance use policy including the impact of alcohol control policies, cannabis policies, and opioid policies on substance use and other health outcomes. He has co-authored more than 100 published manuscripts and book chapters.

Other Positions

  • Professor, Community Health Sciences, Boston University School of Public Health
  • Associate Professor, General Pediatrics, Pediatrics, Boston University Chobanian & Avedisian School of Medicine
  • Faculty, Clinical Addiction Research and Education Unit, Medicine, Boston University Chobanian & Avedisian School of Medicine


  • University of Massachusetts Medical School, MD
  • Harvard University, MPH
  • Harvard College, BA


  • Published on 12/8/2022

    Rice BA, Naimi TS, Long MT. Nonheavy Alcohol Use Associates With Liver Fibrosis and Nonalcoholic Steatohepatitis in the Framingham Heart Study. Clin Gastroenterol Hepatol. 2022 Dec 08. PMID: 36503167.

    Read at: PubMed
  • Published on 11/1/2022

    Blanchette JG, Pacula RL, Smart R, Lira MC, Pessar SC, Naimi TS. The Cannabis Policy Scale: A New Research and Surveillance Tool for U.S. States. J Stud Alcohol Drugs. 2022 Nov; 83(6):829-838. PMID: 36484580.

    Read at: PubMed
  • Published on 11/1/2022

    Esser MB, Leung G, Sherk A, Bohm MK, Liu Y, Lu H, Naimi TS. Estimated Deaths Attributable to Excessive Alcohol Use Among US Adults Aged 20 to 64 Years, 2015 to 2019. JAMA Netw Open. 2022 Nov 01; 5(11):e2239485. PMID: 36318209.

    Read at: PubMed
  • Published on 10/5/2022

    Firas R, Naimi TS. [Not Available]. Rev Med Suisse. 2022 Oct 05; 18(798):1882. PMID: 36200969.

    Read at: PubMed
  • Published on 8/29/2022

    Trangenstein PJ, Tiongson PJD, Lu Y, Lipson SK, Xuan Z, Naimi TS, Jernigan DH. Gender and sexual identity and harms from others' drinking among U.S. college students: Results from a multi-campus survey. J Am Coll Health. 2022 Aug 29; 1-5. PMID: 36036804.

    Read at: PubMed
  • Published on 8/12/2022

    Stockwell T, Zhao J, Alam F, Churchill S, Shi Y, Naimi T. Alcohol sales in Canadian liquor outlets as a predictor of subsequent COVID-19 infection rates: a time-series analysis. Addiction. 2022 Dec; 117(12):3069-3078. PMID: 35913022.

    Read at: PubMed
  • Published on 7/30/2022

    Medling T, Gobeil K, Sawalha K, Abozenah M, Tavares P, Friedmann P, Naimi T, Pack Q. Relation of Patient's Opinion of Alcohol's Health Effects and Drinking Habits Among Hospitalized Patients With Cardiovascular Disease. Am J Cardiol. 2022 Sep 15; 179:31-38. PMID: 35914974.

    Read at: PubMed
  • Published on 5/25/2022

    Blanchette JG, Pacula RL, Smart R, Lira MC, Boustead AE, Caulkins JP, Kilmer B, Kerr WC, Treffers R, Naimi TS. Rating the comparative efficacy of state-level cannabis policies on recreational cannabis markets in the United States. Int J Drug Policy. 2022 Aug; 106:103744. PMID: 35636068.

    Read at: PubMed
  • Published on 4/1/2022

    Lira MC, Naimi TS. Lira and Naimi Respond. Am J Public Health. 2022 Apr; 112(4):e2-e3. PMID: 35319945.

    Read at: PubMed
  • Published on 4/1/2022

    Sherk A, Esser MB, Stockwell T, Naimi TS. Estimating alcohol-attributable liver disease mortality: A comparison of methods. Drug Alcohol Rev. 2022 Jul; 41(5):1245-1253. PMID: 35363378.

    Read at: PubMed

View 178 more publications: View full profile at BUMC

View all profiles